Cargando…
Predictors of relapse after discontinuing systemic treatment in autoimmune chronic uveitis
Autores principales: | Simonini, Gabriele, Bracaglia, Claudia, Cattalini, Marco, Taddio, Andrea, Brambilla, Alice, de Libero, Cinzia, Marafon, Denise Pires, Caputo, Roberto, Cimaz, Rolando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184156/ http://dx.doi.org/10.1186/1546-0096-12-S1-O6 |
Ejemplares similares
-
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2013) -
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
por: Simonini, G, et al.
Publicado: (2011) -
Childhood chronic anterior uveitis associated with vernal keratoconjunctivitis (VKC): successful treatment with topical tacrolimus. Case series
por: Taddio, Andrea, et al.
Publicado: (2011) -
Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008) -
Psoriatic Juvenile Idiopathic Arthritis Associated with Uveitis: A Case Report
por: Moretti, Davide, et al.
Publicado: (2013)